{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:27:26Z","timestamp":1787894846765,"version":"build-2784847793"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T00:00:00Z","timestamp":1334880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035937","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T21:17:43Z","timestamp":1334956663000},"page":"e35937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Enhanced Brain Disposition and Effects of \u03949-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Adena S.","family":"Spiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie A.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/schbul\/sbn108","article-title":"Gene-environment interplay between cannabis and psychosis.","volume":"34","author":"C Henquet","year":"2008","journal-title":"Schizophr Bull"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.","volume":"57","author":"A Caspi","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/npp.2010.100","article-title":"Chronic adolescent exposure to Delta-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.","volume":"35","author":"CM O'Tuathaigh","journal-title":"Neuropsychopharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-007-0721-3","article-title":"Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.","volume":"192","author":"AA Boucher","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuroscience.2007.08.020","article-title":"Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.","volume":"149","author":"AA Boucher","year":"2007","journal-title":"Neuroscience"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S146114571000091X","article-title":"The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.","volume":"14","author":"AA Boucher","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice.","volume":"13","author":"LE Long","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2009.07.003","article-title":"Is resistance useless? Multidrug resistance and collateral sensitivity.","volume":"30","author":"MD Hall","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.","volume":"38","author":"C Cordon-Cardo","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1373\/49.2.230","article-title":"Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.","volume":"49","author":"T Langmann","year":"2003","journal-title":"Clin Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/scbi.1997.0068","article-title":"The physiological function of drug-transporting P-glycoproteins.","volume":"8","author":"AH Schinkel","year":"1997","journal-title":"Semin Cancer Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/dmd.104.001354","article-title":"Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract.","volume":"33","author":"C Zimmermann","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.","volume":"52","author":"S Baltes","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model.","volume":"33","author":"A Doran","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"ref15","article-title":"Opioid transport by ATP-Binding Cassette (ABC) Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology.","author":"N Tournier","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00228-009-0714-8","article-title":"Blood-brain barrier transporters and response to CNS-active drugs.","volume":"65","author":"BL Urquhart","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","article-title":"P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.","volume":"13","author":"NA de Vries","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref18","first-page":"201","article-title":"P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.","volume":"4","author":"JJ Yang","year":"2010","journal-title":"Drug Metab Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1078-0432.CCR-08-2253","article-title":"Brain accumulation of dasatinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatment.","volume":"15","author":"JS Lagas","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.pnpbp.2009.07.016","article-title":"Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence.","volume":"33","author":"A Benyamina","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2008.06.079","article-title":"Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).","volume":"591","author":"ML Holland","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.","volume":"152","author":"ML Holland","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bcp.2005.12.033","article-title":"The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.","volume":"71","author":"ML Holland","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/sj.bjp.0706778","article-title":"Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.","volume":"148","author":"P Nieri","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/jpet.105.098541","article-title":"Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.","volume":"317","author":"HJ Zhu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1369-1600.2008.00096.x","article-title":"Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.","volume":"13","author":"L Bonhomme-Faivre","year":"2008","journal-title":"Addict Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.","volume":"99","author":"JW Jonker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.94.8.4028","article-title":"Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.","volume":"94","author":"AH Schinkel","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1476-5381.2009.00399.x","article-title":"Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure.","volume":"158","author":"N Gunasekaran","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.npp.1301475","article-title":"Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure.","volume":"33","author":"HR Quinn","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref31","article-title":"Cannabidiol potentiates Delta(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.","author":"C Klein","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","article-title":"Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.","volume":"27","author":"P Breedveld","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2009.02.007","article-title":"Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.","volume":"59","author":"MS Warren","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria.","volume":"25","author":"J Kamiie","year":"2008","journal-title":"Pharm Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1054\/plef.2001.0353","article-title":"The role of endocannabinoids in the hypothalamic regulation of visceral function.","volume":"66","author":"T Wenger","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1476-5381.1982.tb08802.x","article-title":"Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.","volume":"75","author":"AG Fitton","year":"1982","journal-title":"Br J Pharmacol"},{"key":"ref37","first-page":"825","article-title":"Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.","volume":"23","author":"LM Bornheim","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2009.04.010","article-title":"Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.","volume":"93","author":"DT Malone","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.","volume":"192","author":"CJ Morgan","year":"2008","journal-title":"Br J Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].","volume":"197","author":"CJ Morgan","year":"2010","journal-title":"Br J Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000125604","article-title":"Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.","volume":"52","author":"LL Murphy","year":"1990","journal-title":"Neuroendocrinology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00213-006-0356-9","article-title":"Interactions between THC and cannabidiol in mouse models of cannabinoid activity.","volume":"186","author":"SA Varvel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bcp.2010.06.025","article-title":"Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion.","volume":"80","author":"SJ Hemauer","journal-title":"Biochem Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.","volume":"48","author":"A Lazarowski","year":"2007","journal-title":"Epilepsia"},{"key":"ref45","article-title":"Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: Clinical significance of in vitro and in vivo findings.","author":"FE O'Brien","journal-title":"Br J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"H Potschka","journal-title":"Epilepsia"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.","volume":"55","author":"AH Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.npp.1300372","article-title":"Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals.","volume":"29","author":"JS Wang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2005.04.039","article-title":"Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.","volume":"234","author":"K Yanase","year":"2006","journal-title":"Cancer Lett"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/schbul\/16.1.81","article-title":"Psychotogenic drug use and neuroleptic response.","volume":"16","author":"MB Bowers Jr","year":"1990","journal-title":"Schizophr Bull"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/09595230412331324554","article-title":"Cannabis use and psychotic disorders: an update.","volume":"23","author":"W Hall","year":"2004","journal-title":"Drug Alcohol Rev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/schbul\/16.1.87","article-title":"Impact of substance abuse on the course and outcome of schizophrenia.","volume":"16","author":"WM Turner","year":"1990","journal-title":"Schizophr Bull"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145704004390","article-title":"The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.","volume":"7","author":"JS Wang","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein.","volume":"103","author":"JS Wang","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.","volume":"97","author":"S Hoffmeyer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:04:39Z","timestamp":1540217079000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035937"}},"subtitle":[],"editor":[{"given":"Silvana","family":"Gaetani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,20]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,20]]}}}